Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

10472	Companies
220554	Keywords
149882	Articles
116640	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 09/05/2025 at 15:05, 8 months 24 days ago

Onco-Innovations Appoints Dr. John Mackey to Advisory Board

Clinical Trials Oncology John Mackey Onco-Innovations PNKP Inhibitor
PRESS RELEASE

published on 09/05/2025 at 15:00, 8 months 24 days ago

Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
Onco-Innovations appoints Dr. John Mackey, expert in oncology and clinical trials, to Scientific & Clinical Advisory Board, enhancing translational research capabilities for PNKP inhibitor program

Clinical Trials Oncology Onco-Innovations PNKP Inhibitor Dr. John Mackey
BRIEF

published on 08/15/2025 at 15:20, 9 months 14 days ago

Onco-Innovations Achieves High Warrant Exercise Rate

Warrants Non-dilutive Financing Cancer Research Shareholder Confidence Capital Strategy
PRESS RELEASE

published on 08/15/2025 at 15:15, 9 months 14 days ago

Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised
Onco-Innovations announces successful execution of key capital strategy with over 90% of outstanding warrants exercised at $0.60, reinforcing investor confidence and internal financing effectiveness

Warrants Investor Confidence Capital Strategy Onco-Innovations Internal Financing
BRIEF

published on 08/13/2025 at 23:05, 9 months 16 days ago

Onco-Innovations Closes $400,000 Private Placement

Private Placement Securities Regulation Shares And Warrants Onco-Innovations Funding And Development
PRESS RELEASE

published on 08/13/2025 at 23:00, 9 months 16 days ago

Onco-Innovations Announces Closing of Private Placement
Onco-Innovations Limited announces the closing of a non-brokered private placement, raising $400,000 for general corporate purposes and cancer research. Statutory hold period applies. Not for distribution in the US

Non-brokered Private Placement Cancer Research Statutory Hold Period Onco-Innovations Limited Not For Distribution
BRIEF

published on 08/04/2025 at 22:10, 9 months 25 days ago

Onco-Innovations Sets Course for Human Trials with Avance Clinical Agreement

Clinical Trial Onco-Innovations PNKP Inhibitor Avance Clinical Regulatory Preparations
PRESS RELEASE

published on 08/04/2025 at 22:05, 9 months 25 days ago

Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
Onco-Innovations partners with Avance Clinical for regulatory and clinical documentation for their PNKP inhibitor therapy. Collaboration aims to advance cancer trials

Clinical Trials Cancer Research Onco-Innovations Regulatory Support Avance Clinical
BRIEF

published on 07/31/2025 at 00:05, 9 months 30 days ago

Inka Health to Lead AI-Driven Oncology Project with OneMedNet

Clinical Trials Oncology Health Innovation Real-world Data AI Analytics
PRESS RELEASE

published on 07/31/2025 at 00:00, 9 months 30 days ago

Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Onco-Innovations Limited's subsidiary, Inka Health Corp., selected by OneMedNet Corporation for data analytics initiative to improve cancer therapy processes and accelerate market entry for new therapies

Real-world Evidence Cancer Therapies Onco-Innovations Limited Inka Health Corp. OneMedNet Corporation

Accesswire

Published on 05/30/2026 at 04:00, 10 hours 45 minutes ago

Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 12 hours 5 minutes ago

BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 13 hours 15 minutes ago

Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 14 hours 14 minutes ago

Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 15 hours 45 minutes ago

The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit

View all ACCESSWIRE

EQS Group

Published on 05/29/2026 at 21:42, 17 hours 2 minutes ago

EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 17 hours 15 minutes ago

Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 20:00, 18 hours 45 minutes ago

Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 18 hours 58 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 19 hours 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/29/2026 at 22:00, 16 hours 45 minutes ago

Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 20 hours 45 minutes ago

Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 17:52, 20 hours 52 minutes ago

Share buyback mandate
Published on 05/29/2026 at 12:00, 1 day 2 hours ago

Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 1 day 4 hours ago

bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market

View all LES ECHOS COMFI WIRE